Trial Profile
The Incidence of Lactic Acidosis During Entecavir Treatment in Chronic Hepatitis B Patients With Severe Cirrhosis or Hepatic Failure
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Adverse reactions
- 21 May 2011 New trial record